CYIOS Corporation is a healthcare and technology company. The Company is principally engaged in supplying medical devices through its wholly-owned subsidiary, Noir Medical Supplies, LLC. It delivers quality products to healthcare providers across the United States and the Caribbean. The Company offers a comprehensive range of products, including personal protective equipment (PPE), diagnostic devices, and essential healthcare items for clinics, hospitals, and medical professionals. The Company is focused on building, acquiring, and operating businesses across multiple industries, including medical supplies, technology, and fintech.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
15/09/26	US$0.001200	0.00%	551,630
14/09/26	US$0.001200	+33.33%	7,953,749
11/09/26	US$0.000900	+5.88%	1,416,000
10/09/26	US$0.000850	-10.53%	1,839,005
09/09/26	US$0.000950	-20.83%	15,045,661

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 20:35:02 15/09/2026 BST			5-day change	1st Jan Change
0.001200 ^USD	0.00%		0.00%	-42.03%

12-02	CYIOS Corporation Announces the Appointment of John O?Shea as New Chairman of the Board	CI
12-02	CYIOS Corporation Announces the Appointment of John O?Shea as New Chief Executive Officer	CI

Market Cap	145K 126K 119K 108K 202K 13.93M 204K 1.42M 546K 7.06M 546K 533K 22.53M	P/E 2010	-1.15x	P/E 2011	7.64x
Enterprise Value	161K 140K 132K 120K 225K 15.49M 226K 1.58M 607K 7.86M 607K 593K 25.05M	EV / Sales 2010	0.28x	EV / Sales 2011	0.48x
Free-Float	78.94%	Yield 2010 *	-	Yield 2011	-

12-02	CYIOS Corporation Announces the Appointment of John O?Shea as New Chairman of the Board	CI
12-02	CYIOS Corporation Announces the Appointment of John O?Shea as New Chief Executive Officer	CI
12-02	Cyios Corp. appoints John O'Shea as chief executive officer to lead next phase of growth and innovation	RE
21/10/25	CYIOS Corporation Announces David Lewis Steps Down from His Roles	CI
10/09/24	CYIOS Corporation acquired Noir Medical Supplies, LLC.	CI
18/08/22	CYIOS Corp ‘s Immortals Group Forms Partnership with MARVELOUS NFT’s, Developer of the Highly Acclaimed Bad Days Super-Hero Play to Earn NFT Game	CI
10/08/22	CYIOS Corporation Immortals Group Details NFT, Web3 & Gaming Partnership Opportunities Including NFT Play to Earn Gaming and NFT Superhero Collection	CI
01/03/22	CYIOS Corp Launches Helio Cypto Exchange	CI
16/02/22	Cyios Corp, Wholly Owned Subsidiary Immortals Group Signs Exclusive Agreement with Stan Lee Holdings Hk for Historic Nft Collection of A “Lost” Stan Lee-Will Meugniot Superhero Franchise	CI
17/11/21	CYIOS Corporation acquired RANDOMBLY, LLC.	CI
12/10/21	CYIOS Corporation Develops A Specialty NFT Platform for Minting, Trading and Lending NFT’s	CI
12/10/21	CYIOS Corporation Announces the Formation of the Formation of New Subsidiary Helio Exchange, Pty	CI
06/05/21	CYIOS Corporation completed the acquisition of Helio Lending.	CI

12-02	CYIOS Corp. Appoints John O’Shea as Chief Executive Officer to Lead Next Phase of Growth and Innovation	AQ
29/10/25	CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations	AQ
21/10/25	CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors	AQ
27/02/23	CYIOS CORPÃ¢€™S HELIO LENDING HAS WEATHERED THE CRYPTO CORRECTION	AQ
12/10/22	CYIOS CORP WHOLLY OWNED SUBSIDIARY IMMORTALS GROUP ANNOUNCES SLAM-GIRL NFT GENESIS COLLECTION NOW AVAILABLE FOR PURCHASE ON THE ONEOF NFT MARKETPLACE	AQ

CYIOS Corporation Share Price

Stocks

CYIO

US23256Y1082

Medical Equipment, Supplies & Distribution

Valuation: CYIOS Corporation

Chart: CYIOS Corporation

Latest news: CYIOS Corporation

Press Releases: CYIOS Corporation

Quotes and Performance

Price Extremes

Managers and Directors: CYIOS Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Current month	-33.33%
1 month	-40.00%
3 months	-29.41%
6 months	-14.29%
Current year	-42.03%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0.01
3 years	0		0.02
5 years	0		0.23
10 years	0		0.84

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYIOS CORPORATION	0.00%	0.00%	-66.67%	-80.95%	510K
ABBOTT LABORATORIES	-1.03%	-3.31%	-22.31%	+0.29%	178B
MEDTRONIC PLC	-0.05%	+1.47%	+0.34%	+14.65%	120B
CENCORA, INC.	-0.90%	-0.43%	+10.94%	+81.33%	62.25B
BECTON, DICKINSON AND COMPANY	+1.65%	+3.81%	+0.10%	-29.51%	49.82B
HOYA CORPORATION	-0.09%	-3.88%	+2.98%	+38.61%	48.54B
DEXCOM, INC.	+2.09%	+2.27%	+14.38%	-10.28%	31.95B
MEDLINE INC.	-1.47%	-7.44%	-	-	28.59B
WEST PHARMACEUTICAL SERVICES, INC.	+2.76%	+8.07%	+41.73%	-7.40%	25B
TERUMO CORPORATION	+0.49%	-0.64%	-10.59%	+4.21%	21.59B
Average	+0.35%	-1.09%	-3.23%	+1.22%	56.61B
Weighted average by Cap.	-0.11%	-1.28%	-3.41%	+12.75%

	2010	2011
Net sales	1.85M 1.6M 1.52M 1.37M 2.57M 177M 2.59M 18.08M 6.96M 89.97M 6.95M 6.79M 287M	1.93M 1.67M 1.58M 1.43M 2.68M 185M 2.7M 18.83M 7.24M 93.69M 7.24M 7.08M 299M
Net income	-394K -341K -323K -292K -548K -37.8M -553K -3.85M -1.48M -19.17M -1.48M -1.45M -61.12M	119K 103K 97.39K 88.17K 165K 11.41M 167K 1.16M 447K 5.78M 447K 437K 18.44M
Net Debt	59.86K 51.85K 49.03K 44.39K 83.31K 5.74M 83.94K 585K 225K 2.91M 225K 220K 9.29M	16.25K 14.08K 13.31K 12.05K 22.62K 1.56M 22.79K 159K 61.12K 791K 61.05K 59.7K 2.52M